Literature DB >> 15347344

NBCCS secondary to an interstitial chromosome 9q deletion.

M A Haniffa1, S N Leech, S A Lynch, N B Simpson.   

Abstract

Naevoid basal cell carcinoma syndrome (NBCCS) or Gorlin syndrome is a rare autosomal dominant cancer disorder. The Gorlin's gene, Patched 1 (PTCH1), maps to Chromosome 9q. Germline mutations of PTCH1 occur in patients with NBCCS. The subsequent loss of the remaining allele results in cancer formation. We present a patient with NBCCS and additional phenotypic features including severe developmental delay, short stature and hypotelorism who was found to have an interstitial chromosome 9q deletion. The NBCCS phenotype in our patient occurred as a result of PTCH1 deletion in contrast with an inherited mutation of this gene.

Entities:  

Mesh:

Year:  2004        PMID: 15347344     DOI: 10.1111/j.1365-2230.2004.01590.x

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN: 0307-6938            Impact factor:   3.470


  4 in total

1.  9q22 Deletion--first familial case.

Authors:  Linda Siggberg; Maarit Peippo; Marjatta Sipponen; Taina Miikkulainen; Keiko Shimojima; Toshiyuki Yamamoto; Jaakko Ignatius; Sakari Knuutila
Journal:  Orphanet J Rare Dis       Date:  2011-06-22       Impact factor: 4.123

Review 2.  Nevoid basal cell carcinoma syndrome (Gorlin syndrome).

Authors:  Lorenzo Lo Muzio
Journal:  Orphanet J Rare Dis       Date:  2008-11-25       Impact factor: 4.123

3.  High-density oligonucleotide array with sub-kilobase resolution reveals breakpoint information of submicroscopic deletions in nevoid basal cell carcinoma syndrome.

Authors:  Katsunori Fujii; Shumpei Ishikawa; Hideki Uchikawa; Daisuke Komura; Michael H Shapero; Fan Shen; Jing Hung; Hiroshi Arai; Yoko Tanaka; Kimio Sasaki; Yoichi Kohno; Masao Yamada; Keith W Jones; Hiroyuki Aburatani; Toshiyuki Miyashita
Journal:  Hum Genet       Date:  2007-08-17       Impact factor: 4.132

4.  PTCH mutations and deletions in patients with typical nevoid basal cell carcinoma syndrome and in patients with a suspected genetic predisposition to basal cell carcinoma: a French study.

Authors:  N Soufir; B Gerard; M Portela; A Brice; M Liboutet; P Saiag; V Descamps; D Kerob; P Wolkenstein; I Gorin; C Lebbe; N Dupin; B Crickx; N Basset-Seguin; B Grandchamp
Journal:  Br J Cancer       Date:  2006-08-21       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.